Ren, Xiaoxiao <br/><br/>
Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.  [electronic resource] 

 -  Dermatology (Basel, Switzerland)  2009 
 - 232-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1421-9832 
<br/><br/><label>Standard No.: </label>10.1159/000235974  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Ear--pathology<br/>Gene Expression<br/>Immunohistochemistry<br/>Injections<br/>Injections, Subcutaneous<br/>Interferon-gamma--biosynthesis<br/>Interleukin-4--administration & dosage<br/>Mice<br/>Mice, Transgenic<br/>Neovascularization, Pathologic--pathology<br/>Psoriasis--drug therapy<br/>RNA, Messenger--genetics<br/>Recombinant Proteins--administration & dosage<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--metabolism